$LAB

LAB crypto falls 13% despite dip buying – Can bulls defend $0.12?

Lab (LAB) fell more than 13% in 24 hours, extending a downtrend, with daily volume up 335% to about $50M and a volume-to-market-cap ratio near 81%, according to the article. It cites technical rejection around $0.15, rising open interest above $124M, exchange hot-wallet selling (KuCoin), and protocol daily revenue dropping from about $191K to about $6.2K.

Original reporting
Published Aug 6, 2026, 1:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 2:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
LAB crypto falls 13% despite dip buying – Can bulls defend $0.12? — source image
Decision brief

The 30-second read

$LABBearishMed
01

Why it matters

The article links the selloff to technical rejection, rising open interest consistent with short selling, CVD showing distribution, exchange hot-wallet selling, and a sharp drop in reported daily protocol revenue, plus liquidation of longs.

02

Market read

Traders get a near-term trading read on LAB: breakdown below a key range level, derivatives positioning turning bearish, and exchange outflows coinciding with a revenue collapse narrative.

03

What to watch

The piece is heavily technical and on-chain/derivatives focused; it does not confirm whether the reported exchange outflows translate into sustained spot selling versus hedging or transfers.

Relevance 6/10Novelty 5/10Timing: at press time, during the last 24 hours selloff

Background

LAB has been trading in a mid-July range between $0.1264 and $0.1726 before breaking down below the $0.15 midpoint.

Company-level read

Ticker impact

$LABBearishMedium confidence
Context

LAB is down more than 13% as selling pressure spikes, with rising open interest and CVD showing token distribution near $0.1270 support.

Expected impact

Near-term downside risk remains elevated unless $0.1270 support stabilizes; otherwise, further liquidation-driven selling is likely.

Evidence & confidence

The article cites a breakdown below the $0.15 range mid-level, rising open interest during the drop, CVD distribution, KuCoin hot-wallet selling, and long liquidations, offset by a higher long/short ratio on Binance and OKX.

Market effects

Highlights typical altcoin microstructure risk: exchange hot-wallet outflows, revenue collapse narrative, and derivatives positioning amplifying moves.

None specified.

None specified.

Counterpoint

The long/short ratios (3.50 Binance, 10 OKX) suggest some traders are buying the dip, which can fuel a fast mean-reversion bounce if liquidation pressure eases.

Key entities

  • LAB

    The token experiencing a 13%+ drop, with derivatives and on-chain indicators pointing to heavy selling and short positioning.

  • KuCoin

    Reportedly selling LAB tokens from hot wallets, with transfers to Bitget and Gate.

  • Binance

    Reportedly showing long/short ratio changes and receiving tokens via proxy wallets; also cited for liquidation/positioning context.

  • OKX

    Reportedly showing a high long/short ratio (10), implying dip-buying interest.

Related articles

$LABMed

Standard BioTools Reports Second Quarter 2026 Financial Results

STANDARD BIOTOOLS INC. (LAB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Standard BioTools Reports Second Quarter 2026 Financial Results BOSTON, Mass., August 5, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended June 30, 2026. Recent

$NEAR-USDMed

Bitwise NEAR ETF Launch Highlighted by NEAR Co-Founder

NEAR co-founder Ilblackdragon discussed the launch of the Bitwise NEAR ETF, which aims to attract institutional investors to the NEAR ecosystem. The ETF could enhance NEAR's visibility and market influence, potentially stabilizing its position amid current crypto market volatility. NEAR's price is currently at $0, but the ETF may increase trading volume.

$ENA-USDMed

Standard Chartered says Ethena's ENA could crush Bitcoin and Ethereum returns by 2028

Standard Chartered predicts Ethena's ENA token could reach $2 by 2028, a 7x increase from current levels, outperforming Bitcoin and Ethereum returns. This growth hinges on USDe supply expanding to $40 billion, reversing its current contraction and scaling new yield sources. The bank's forecast assumes Ethena can diversify its revenue streams and maintain competitive yields.

Med

OUSD Stablecoin Goes Live With Visa, Mastercard And Stripe Behind It

Open Standard launched OUSD, a dollar-pegged stablecoin backed by Visa, Mastercard, Stripe, Coinbase, and Shopify. Over 200 partners, including Google and BlackRock, support the initiative. The founding partners committed $1 billion for initial liquidity. OUSD trades on major exchanges and can be minted/redeemed through partner platforms. The stablecoin operates on four blockchains and aims to integrate into business payment systems.

$XRP-USDHigh

XRP Surges 3.32% on Nasdaq Treasury Vote Confirmation

XRP surged 3.32% in 7 hours following news that Evernorth, a Ripple-backed firm, passed a shareholder vote for a Nasdaq listing under ticker XRPN. Evernorth plans to hold 473 million XRP for infrastructure and liquidity. The move was amplified by derivatives positioning and short liquidations. XRP's price rebounded from $1.47 to above $1.50 on the news, with heavy short liquidations in the $1.50-$1.55 range.